1. Redox regulation of metabolic syndrome: recent developments in skeletal muscle insulin resistance and non-alcoholic fatty liver disease (NAFLD)
   Yee Hui Yeo et al, 2019, Current Opinion in Physiology CrossRef
2. Oxidative Stress and Pro-Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease
   Margalida Monserrat-Mesquida et al, 2020, Antioxidants CrossRef
3. Lung injury induced by short-term mechanical ventilation with hyperoxia and its mitigation by deferoxamine in rats
   Xiao-Xia Wang et al, 2020, BMC Anesthesiology CrossRef
4. Effect of palmitate-induced steatosis on paraoxonase-1 and paraoxonase-3 enzymes in human-derived liver (HepG2) cells
   Gülben SAYILAN ÖZGÜN et al, 2019, Archives of Clinical and Experimental Medicine CrossRef
5. A review of experimental and clinical studies on the therapeutic effects of pomegranate (Punica granatum) on non‐alcoholic fatty liver disease: Focus on oxidative stress and inflammation
   Mohammad Yassin Zamanian et al, 2023, Food Science & Nutrition CrossRef
6. First-line anti-tuberculosis drugs induce hepatotoxicity: A novel mechanism based on a urinary metabolomics platform
   Jun Cao et al, 2018, Biochemical and Biophysical Research Communications CrossRef
7. Paraoxonase-1 Serum Concentration and PON1 Gene Polymorphisms: Relationship with Non-Alcoholic Fatty Liver Disease
   Mircea Vasile Milaciu et al, 2019, Journal of Clinical Medicine CrossRef
8. Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD)
   Robin C. Su et al, 2019, PLOS ONE CrossRef
9. Lipoic Acid Exacerbates Oxidative Stress and Lipid Accumulation in the Liver of Wistar Rats Fed a Hypercaloric Choline-Deficient Diet
   Lidia V. Kravchenko et al, 2021, Nutrients CrossRef
10. Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterol
    Eline H. van den Berg et al, 2019, Journal of Lipid Research CrossRef
11. Glycoprotein levels and oxidative lung injury in experimental diabetes: effect of oxovanadium(IV) complex based on thiosemicarbazone
    Bertan Boran Bayrak et al, 2021, Toxicology Mechanisms and Methods CrossRef
12. Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
    Sara Karami et al, 2021, Diabetology & Metabolic Syndrome CrossRef
13. The Relationship between Cancer and Paraoxonase 1
    Irma Martha Medina-Díaz et al, 2022, Antioxidants CrossRef
14. The 5-HT1A Agonist Buspirone Decreases Liver Oxidative Stress and Exerts Protective Effect Against CCl4– Toxicity
    Omar M.E. Abdel-Salam et al, 2017, Journal of Experimental and Clinical Toxicology CrossRef
15. Hepatoprotective Effects of a Novel Trihoney against Nonalcoholic Fatty Liver Disease: A Comparative Study with Atorvastatin
    Hamad Abdulsalam Hamad Alfarisi et al, 2020, The Scientific World Journal CrossRef
16. Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways
    Yanan Lv et al, 2019, The Journal of Nutritional Biochemistry CrossRef
17. Quercetin ameliorates the hepatic apoptosis of foetal rats induced by in utero exposure to fenitrothion via the transcriptional regulation of paraoxonase-1 and apoptosis-related genes
    Khairy A. Ibrahim et al, 2021, Biomarkers CrossRef
18. Effects of dexmedetomidine on the function of distal organs and oxidative stress after lower limb ischaemia–reperfusion in elderly patients undergoing unilateral knee arthroplasty
    Sunshan Lu et al, 2021, British Journal of Clinical Pharmacology CrossRef
19. Evaluation of the prognostic value of paraoxonase 1 in the recurrence and metastasis of hepatocellular carcinoma and establishment of a liver-specific predictive model of survival
    Zheng Yu et al, 2018, Journal of Translational Medicine CrossRef
20. Hepatotoxicity assessment of Rhizoma Paridis in adult zebrafish through proteomes and metabolome
    Zhe Jia et al, 2020, Biomedicine & Pharmacotherapy CrossRef
21. Paraoxonase 1 and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis
    Kazuhiko Kotani et al, 2021, Molecules CrossRef